CADL
Price
$1.75
Change
-$0.01 (-0.57%)
Updated
Feb 23, 6:59 PM EST
32 days until earnings call
MDGL
Price
$236.54
Change
-$11.99 (-4.82%)
Updated
Feb 23, 6:59 PM EST
2 days until earnings call
Ad is loading...

CADL vs MDGL ᐉ Comparison: Which is Better to Invest?

Header iconCADL vs MDGL Comparison
Open Charts CADL vs MDGLBanner chart's image
Candel Therapeutics
Price$1.75
Change-$0.01 (-0.57%)
Volume$64.2K
CapitalizationN/A
Madrigal Pharmaceuticals
Price$236.54
Change-$11.99 (-4.82%)
Volume$207.42K
CapitalizationN/A
View a ticker or compare two or three
CADL vs MDGL Comparison Chart

Loading...

MDGLDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
CADL vs. MDGL commentary
Feb 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CADL is a Hold and MDGL is a Hold.

COMPARISON
Comparison
Feb 25, 2024
Stock price -- (CADL: $1.75 vs. MDGL: $236.54)
Brand notoriety: CADL and MDGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CADL: 83% vs. MDGL: 103%
Market capitalization -- CADL: $50.61M vs. MDGL: $4.67B
CADL [@Biotechnology] is valued at $50.61M. MDGL’s [@Biotechnology] market capitalization is $4.67B. The market cap for tickers in the [@Biotechnology] industry ranges from $550.21B to $0. The average market capitalization across the [@Biotechnology] industry is $2.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CADL’s FA Score shows that 0 FA rating(s) are green whileMDGL’s FA Score has 0 green FA rating(s).

  • CADL’s FA Score: 0 green, 5 red.
  • MDGL’s FA Score: 0 green, 5 red.
According to our system of comparison, MDGL is a better buy in the long-term than CADL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MDGL’s TA Score shows that 7 TA indicator(s) are bullish.

  • MDGL’s TA Score: 7 bullish, 4 bearish.

Price Growth

CADL (@Biotechnology) experienced а +1.74% price change this week, while MDGL (@Biotechnology) price change was +1.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.03%. For the same industry, the average monthly price growth was +18.51%, and the average quarterly price growth was +38.88%.

Reported Earning Dates

CADL is expected to report earnings on May 09, 2024.

MDGL is expected to report earnings on May 07, 2024.

Industries' Descriptions

@Biotechnology (+2.03% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for CADL with price predictions.
OPEN
A.I.dvisor published
a Summary for MDGL with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
MDGL($4.67B) has a higher market cap than CADL($50.6M). CADL YTD gains are higher at: 19.048 vs. MDGL (2.230). CADL has higher annual earnings (EBITDA): -46.08M vs. MDGL (-336.4M). MDGL has more cash in the bank: 232M vs. CADL (43M). CADL has less debt than MDGL: CADL (22.8M) vs MDGL (117M). CADL has higher revenues than MDGL: CADL (31K) vs MDGL (0).
CADLMDGLCADL / MDGL
Capitalization50.6M4.67B1%
EBITDA-46.08M-336.4M14%
Gain YTD19.0482.230854%
P/E Ratio46.08N/A-
Revenue31K0-
Total Cash43M232M19%
Total Debt22.8M117M19%
FUNDAMENTALS RATINGS
MDGL: Fundamental Ratings
MDGL
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
PROFIT vs RISK RATING
1..100
44
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MDGL
RSI
ODDS (%)
Bullish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 9 days ago
78%
Declines
ODDS (%)
Bearish Trend 4 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
74%
View a ticker or compare two or three
Ad is loading...
MDGLDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IFRA40.140.23
+0.58%
iShares US Infrastructure ETF
XHYF36.880.06
+0.16%
BondBloxx US Hg Yld Fncl & REIT Str ETF
EEMA66.850.07
+0.10%
iShares MSCI Emerging Markets Asia ETF
TOLZ44.67-0.01
-0.03%
ProShares DJ Brookfield Global Infras
MDEV21.00-0.04
-0.21%
First Trust Indxx Global Mdcl Dvcs ETF

CADL and

Correlation & Price change

A.I.dvisor tells us that CADL and MDGL have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CADL and MDGL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CADL
1D Price
Change %
CADL100%
+0.99%
MDGL - CADL
33%
Poorly correlated
-4.82%
KRRO - CADL
31%
Poorly correlated
-2.39%
SRNEQ - CADL
31%
Poorly correlated
+164.00%
GTHX - CADL
27%
Poorly correlated
+3.26%
DSGN - CADL
27%
Poorly correlated
-0.71%
More

MDGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, MDGL has been loosely correlated with IBRX. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if MDGL jumps, then IBRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDGL
1D Price
Change %
MDGL100%
-4.82%
IBRX - MDGL
62%
Loosely correlated
-33.21%
KA - MDGL
62%
Loosely correlated
-3.45%
VXRT - MDGL
61%
Loosely correlated
-9.29%
SRNEQ - MDGL
58%
Loosely correlated
+164.00%
RLAY - MDGL
57%
Loosely correlated
-5.39%
More